Understanding GLP-1 and Glucose Homeostasis Regulation
Glucagon-like peptide-1 (GLP-1) is a secreted peptide that plays a crucial role in regulating blood glucose levels. It acts as an incretin hormone, stimulating insulin secretion and suppressing glucagon release, thereby contributing to glucose homeostasis. The GLP-1 receptor (GLP-1R) is a G protein-coupled receptor that is activated directly or indirectly by blood glucose-lowering agents, currently in use for the treatment of type 2 diabetes mellitus (T2DM).Mechanisms of GLP-1 Action
GLP-1 exerts its therapeutic effects through multiple mechanisms, including glucose-dependent insulin secretion from pancreatic β-cells, inhibition of glucagon release, delayed gastric emptying via vagal pathways, and central appetite suppression through hypothalamic and brainstem receptors. Released GLP-1 activates enteric and autonomic reflexes while also circulating as an incretin hormone to control endocrine pancreas function.Regulation of Glucose Levels
Blood sugar regulation is the process by which the level of blood sugar, the common name for glucose dissolved in blood plasma, is maintained by the body within a narrow range. This tight regulation is referred to as glucose homeostasis. The GLP-1 receptor is a key player in this process, mediating the actions of GLP-1 on glucose metabolism.GLP-1 and Energy Balance
GLP-1-Based Multi-Receptor Agonists
GLP-1-based multi-receptor agonists have emerged as a promising class of drugs for targeting key aging processes and restoring cellular homeostasis. These agents activate multiple receptors, including the GLP-1 receptor, to enhance glucose-dependent insulin secretion, improve glycemic control, and contribute to lipid homeostasis.Impact on Glucose Homeostasis
GLP-1 agonists have been shown to improve glucose homeostasis by enhancing glucose-dependent insulin secretion, suppressing glucagon release, and delaying gastric emptying. They have also been found to reduce appetite and food intake, supporting their clinical use in obesity and type 2 diabetes.Nutrient Sensing and GLP-1 Secretion
